Optic neuritis is the presenting sign of MS in up to 30 percent of patients, so optometrists can play a vital role in initial diagnosis and effective treatment.
Treatment and prevention of myopia are limited by a lack of understanding of its underlying mechanisms. However, a recent animal study has uncovered key signaling pathways that may be responsible for the retinal responses to defocus and are therefore potential therapeutic targets.
Various factors, including a compounded reduction in contrast sensitivity and reduced reading speed, mean that multifocal IOLs are not ideal for patients with early or subclinical AMD. It is therefore imperative to identify such patients–using a simple practice tool–and enable them to make an informed choice preoperatively.
